Weighted Average Number of Shares Outstanding, Basic of Regen BioPharma Inc from Q1 2013 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Regen BioPharma Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q1 2013 to Q2 2025.
  • Regen BioPharma Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2025 was 23.8M shares, a 464% increase year-over-year.
  • Regen BioPharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 4.11M shares, a 16.2% increase from 2023.
  • Regen BioPharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 3.54M shares, a 12.8% increase from 2022.
  • Regen BioPharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.14M shares, a 99.9% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Regen BioPharma Inc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 23.8M +19.5M +464% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 21.6M +17.4M +424% 01 Jan 2025 31 Mar 2025 10-Q 28 May 2025
Q4 2024 4.11M +514K +14.3% 01 Oct 2024 31 Dec 2024 10-Q 16 May 2025
Q3 2024 4.11M +573K +16.2% 01 Jul 2024 30 Sep 2024 10-K 13 May 2025
Q2 2024 4.21M +832K +24.6% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 4.11M +2.45M +148% 01 Jan 2024 31 Mar 2024 10-Q 28 May 2025
Q4 2023 3.6M +235K +7.01% 01 Oct 2023 31 Dec 2023 10-Q 16 May 2025
Q3 2023 3.54M +401K +12.8% 01 Jul 2023 30 Sep 2023 10-K 13 May 2025
Q2 2023 3.38M +192K +6.03% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 1.66M -1.39M -45.6% 01 Jan 2023 31 Mar 2023 10-Q 24 Apr 2024
Q4 2022 3.36M -4.5B -99.9% 01 Oct 2022 31 Dec 2022 10-Q 19 Jan 2024
Q3 2022 3.14M -3.01B -99.9% 01 Jul 2022 30 Sep 2022 10-K 20 Nov 2023
Q2 2022 3.19M -3.57B -99.9% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023
Q1 2022 3.04M -2.45B -99.9% 01 Jan 2022 31 Mar 2022 10-Q 18 Apr 2023
Q4 2021 4.51B +2.74B +155% 01 Oct 2021 31 Dec 2021 10-Q 19 Jan 2023
Q3 2021 3.01B +1.6B +114% 01 Jul 2021 30 Sep 2021 10-K 15 Nov 2022
Q2 2021 3.57B +1.97B +123% 01 Apr 2021 30 Jun 2021 10-Q/A 22 Dec 2021
Q1 2021 2.46B +882M +56% 01 Jan 2021 31 Mar 2021 10-Q 18 Aug 2021
Q4 2020 1.77B +933M +112% 01 Oct 2020 31 Dec 2020 10-Q 20 Jan 2022
Q3 2020 1.41B -661M -31.9% 01 Jul 2020 30 Sep 2020 10-K 22 Dec 2021
Q2 2020 1.61B +1.52B +1769% 01 Apr 2020 30 Jun 2020 10-Q/A 22 Dec 2021
Q1 2020 1.58B +1.28B +433% 01 Jan 2020 31 Mar 2020 10-Q 18 Aug 2021
Q4 2019 836M +624M +295% 01 Oct 2019 31 Dec 2019 10-Q 13 Aug 2021
Q3 2019 2.07B +1.92B +1262% 01 Jul 2019 30 Sep 2019 10-K 04 Aug 2021
Q2 2019 85.9M -67.6M -44.1% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2021
Q1 2019 296M +150M +103% 01 Jan 2019 31 Mar 2019 10-Q 05 Aug 2021
Q4 2018 212M +68.8M +48.1% 01 Oct 2018 31 Dec 2018 10-Q 05 Aug 2021
Q3 2018 152M +10.7M +7.54% 01 Jul 2018 30 Sep 2018 10-K 21 Jun 2021
Q2 2018 154M +15.4M +11.1% 01 Apr 2018 30 Jun 2018 10-Q 24 Oct 2019
Q1 2018 145M +3.57M +2.52% 01 Jan 2018 31 Mar 2018 10-Q 29 Aug 2019
Q4 2017 143M -519K -0.36% 01 Oct 2017 31 Dec 2017 10-Q 12 Feb 2019
Q3 2017 141M +13.6M +10.6% 01 Jul 2017 30 Sep 2017 10-K 27 Dec 2018
Q2 2017 138M +9.35M +7.26% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018
Q1 2017 142M +16.9M +13.5% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 144M +25.4M +21.5% 01 Oct 2016 31 Dec 2016 10-Q 27 Jan 2017
Q3 2016 128M +39.7M +45% 01 Jul 2016 30 Sep 2016 10-K 21 Dec 2016
Q2 2016 129M +18.1M +16.4% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2016
Q1 2016 125M +52.9M +73.5% 01 Jan 2016 31 Mar 2016 10-Q 29 Apr 2016
Q4 2015 118M +66.2M +127% 01 Oct 2015 31 Dec 2015 10-Q 27 Jan 2017
Q3 2015 88.2M +36.5M +70.5% 01 Jul 2015 30 Sep 2015 10-K 21 Dec 2016
Q2 2015 111M +58.7M +113% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016
Q1 2015 72M +20.1M +38.7% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016
Q4 2014 52M +236K +0.46% 01 Oct 2014 31 Dec 2014 10-Q/A 28 Apr 2017
Q3 2014 51.7M 01 Jul 2014 30 Sep 2014 10-K/A 28 Apr 2017
Q2 2014 51.9M +27.7M +115% 01 Apr 2014 30 Jun 2014 10-Q/A 28 Apr 2017
Q1 2014 51.9M +51.9M 01 Jan 2014 31 Mar 2014 10-Q/A 28 Apr 2017
Q4 2013 51.8M 01 Oct 2013 31 Dec 2013 10-Q 04 Feb 2015
Q2 2013 24.2M 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014
Q1 2013 10K* 01 Jan 2013 31 Mar 2013 10-Q 05 May 2014

Regen BioPharma Inc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 4.11M +573K +16.2% 01 Oct 2023 30 Sep 2024 10-K 13 May 2025
2023 3.54M +401K +12.8% 01 Oct 2022 30 Sep 2023 10-K 13 May 2025
2022 3.14M -3.01B -99.9% 01 Oct 2021 30 Sep 2022 10-K 20 Nov 2023
2021 3.01B +1.6B +114% 01 Oct 2020 30 Sep 2021 10-K 15 Nov 2022
2020 1.41B -661M -31.9% 01 Oct 2019 30 Sep 2020 10-K 22 Dec 2021
2019 2.07B +1.92B +1262% 01 Oct 2018 30 Sep 2019 10-K 04 Aug 2021
2018 152M +10.7M +7.54% 01 Oct 2017 30 Sep 2018 10-K 21 Jun 2021
2017 141M +13.6M +10.6% 01 Oct 2016 30 Sep 2017 10-K 27 Dec 2018
2016 128M +39.7M +45% 01 Oct 2015 30 Sep 2016 10-K 21 Dec 2016
2015 88.2M +36.5M +70.5% 01 Oct 2014 30 Sep 2015 10-K 21 Dec 2016
2014 51.7M +32.8M +173% 01 Oct 2013 30 Sep 2014 10-K/A 28 Apr 2017
2013 19M 01 Oct 2012 30 Sep 2013 10-K 18 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.